文献速递骨肿瘤小儿骨科

儿童与成人下肢肿瘤假体重建术后功能改善程度相似

Pediatric and Adult Patients Have Similar Functional Improvement After Endoprosthetic Reconstruction of Lower-Extremity Tumors.
PubMed 文献 · J Bone Joint Surg Am · 2023-07-19

基于PARITY试验前瞻性数据库,纳入150例儿童和447例成人下肢骨肿瘤患者,比较假体重建术前及术后3、6、12个月的MSTS-93和TESS评分。儿童组基线及术后1年功能评分均高于成人组,但两组从基线至术后1年的平均改善程度相似。

要点

  • 儿童组基线MSTS-93评分64.7高于成人组53.8(p<0.001),TESS评分73.4高于成人组60.4(p<0.001)。
  • 术后1年儿童组MSTS-93评分82.0高于成人组76.8(p=0.02),TESS评分87.7高于成人组78.6(p<0.001)。
  • 两组从基线至术后1年MSTS-93平均改善差异17.4 vs 20.0(p=0.48),TESS平均改善差异14.1 vs 14.7(p=0.83)。

核心结论

  • 儿童患者术后几乎所有纳入时间点的功能结局均显著优于成人患者。
  • 但儿童与成人患者术后1年功能评分的平均改善程度相似。
  • 这些发现可能有助于指导接受肿瘤重建手术患者的术后预期。

研究设计与样本

  • 研究数据来自前瞻性收集的PARITY(肿瘤手术预防性抗生素方案)试验数据库。
  • 纳入150例儿童和447例成人下肢骨肿瘤患者。
  • 术前及术后3、6、12个月 administered MSTS-93和TESS问卷。
  • 连续变量采用Student t检验比较,二分类变量采用Pearson卡方检验比较。
  • 证据等级为预后II级。

主要发现

  • 儿童组原发骨肿瘤比例高于成人组(146/150 vs 287/447,p<0.001)。
  • 儿童组接受辅助化疗比例高于成人组(140/149 vs 195/441,p<0.001)。
  • 两组再手术率无显著差异(儿童45/105 vs 成人106/341,p≤0.13)。
  • 儿童组基线MSTS-93评分64.7高于成人组53.8(p<0.001),TESS评分73.4高于成人组60.4(p<0.001)。
  • 术后1年儿童组MSTS-93评分82.0高于成人组76.8(p=0.02),TESS评分87.7高于成人组78.6(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the treatment of lower-extremity bone tumors is similar between adult and pediatric patients, differences in outcomes are unknown. Outcomes for lower-extremity oncologic reconstruction have been challenging to study because of the low incidence and heterogeneity in disease and patient characteristics. The PARITY (Prophylactic Antibiotic Regimens in Tumor Surgery) trial is the largest prospective data set assembled to date for patients with lower-extremity bone tumors and presents an opportunity to investigate differences in outcomes between these groups. METHODS: Patient details were acquired from the prospectively collected PARITY trial database. The 1993 Musculoskeletal Tumor Society (MSTS-93) and Toronto Extremity Salvage Score (TESS) questionnaires were administered preoperatively and at 3, 6, and 12 months postoperatively. Continuous outcomes were compared between groups with use of the Student t test, and dichotomous outcomes were compared with use of the Pearson chi-square test. RESULTS: A total of 150 pediatric and 447 adult patients were included. Pediatric patients were more likely than adult patients to have a primary bone tumor (146 of 150 compared with 287 of 447, respectively; p < 0.001) and to have received adjuvant chemotherapy (140 of 149 compared with 195 of 441, respectively; p < 0.001). Reoperation rates were not significantly different between age groups (45 of 105 pediatric patients compared with 106 of 341 adult patients; p ≤ 0.13). Pediatric patients had higher mean MSTS-93 scores (64.7 compared with 53.8 among adult patients; p < 0.001) and TESS (73.4 compared with 60.4 among adult patients; p < 0.001) at baseline, which continued to 1 year postoperatively (mean MSTS-93 score, 82.0 compared with 76.8 among adult patients; p = 0.02; mean TESS, 87.7 compared with 78.6 among adult patients; p < 0.001). Despite the differences in outcomes between cohorts, pediatric and adult patients demonstrated similar improvement in MSTS-93 scores (mean difference, 17.4 and 20.0, respectively; p = 0.48) and TESS (mean difference, 14.1 and 14.7, respectively; p = 0.83) from baseline to 1 year postoperatively. CONCLUSIONS: Pediatric patients had significantly better functional outcomes than adult patients at nearly all of the included postoperative time points; however, pediatric and adult patients showed similar mean improvement in these outcomes at 1 year postoperatively. These findings may be utilized to help guide the postoperative expectations of patients undergoing oncologic reconstruction. LEVEL OF EVIDENCE: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Tran TH, Hayden JB, Gazendam AM, et al. Pediatric and Adult Patients Have Similar Functional Improvement After Endoprosthetic Reconstruction of Lower-Extremity Tumors. J Bone Joint Surg Am. 2023. PMID: 37466576. doi:10.2106/JBJS.22.01049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。